Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

June 01, 2005 (Vol. 25, No. 11)

Optimizing the Drug Target Search

Companies Need to Shorten Their Product Development Timelines or Reduce Attrition

  • The last few years have seen some dramatic changes in the field of drug discovery, but there is an urgent need to make R&D more cost effective, according to Alex Matter, Ph.D., director of the Novartis Institute for Tropical Diseases (Singapore). Dr. Matter was addressing the 8th annual "MipTec" ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.